New Medicines in Development
Today, over 3,050 new medicines are in development. Many of these potential new medicines will fail in clinical trials, but some may represent tomorrow's new treatments. Bringing each new medicine to patients will require, on average, 10 to 15 years of testing and review.[i]
This database includes medicines currently in clinical trials or at FDA for review. The information contained in this database was derived from Wolters Kluwer Health's Adis R&D Insight database and is published with permission under license with Wolters Kluwer Health. PhRMA has not reviewed or verified this information.
Explore our database of new medicines in development and find out what the future may hold.
Alzheimer's Disease
There are currently 98 medicines in development by America's biopharmaceutical companies to treat dementia, mostly Alzheimer's Disease. Read more
Arthritis
The are 198 medicines currently in development to help the more than 50 million Americans afflicted with at least one of the 100 different musculoskeletal disorders.
Read more
Biotechnology Medicines
America’s pharmaceutical research and biotechnology companies are testing a record 901 new biotech medicines and vaccines.
Read more
Cancer
There are 887 medicines in development to treat patients with cancer. These treatments include 122 for lung cancer and 107 for breast cancer. Read more
Children
America’s pharmaceutical research and biotechnology companies are developing 282 medicines for the special health care needs of children. Read more
Diabetes
There are a record 235 new diabetes medicines currently in development to help treat diabetes. Read more
Heart Disease and Stroke
Nearly 300 potential medicines to treat heart disease and stroke are in the research pipeline. Read more
HIV/AIDS
Pharmaceutical researchers are testing nearly 90 medicines and vaccines to treat or prevent HIV/AIDS and related conditions. Read more
Infectious Diseases
America’s biopharmaceutical research companies have 395 new medicines and vaccines in the pipeline to fight infectious diseases — all in later stages of development. Read more
Mental Health Disorders
More than 300 medicines are in development to help treat mental an estimated 60 million American adults who suffer from mental health disorders. Read more
Neurological Conditions
America’s pharmaceutical research companies are testing 547 new medicines to help treat neurological conditions. Learn more about potential medicines for Alzheimer's, Parkinson’s, epilepsy, sleep disorders, brain tumors, and many others. Read more
Older Americans
More than 2,000 medicines for older Americans are currently being tested in clinical trials or are waiting for Food and Drug Administration approval. Read more
Rare Diseases
There are 460 medicines currently in development to treat or prevent hundreds of rare diseases. Read more
Skin Diseases
There are currently 277 medicines in development to help the more than 100 million Americans, one third of the U.S. population, that suffer from at least one skin disease. Read more
Women
Currently, there are 851 medicines in development for diseases that disproportionately or only affect women. Read more
[i] J. A. DiMasi, “New Drug Development in U.S. 1963–1999,” Clinical Pharmacology & Therapeutics 69, no. 5 (2001): 286–296; M. Dickson and J. P. Gagnon, “Key Factors in the Rising Cost of New Drug Discovery and Development,” Nature Reviews Drug Discovery 3 (May 2004): 417–429; J. A. DiMasi, R. W. Hansen, and H. G. Grabowski, “The Price of Innovation: New Estimates of Drug Development Costs,” Journal of Health Economics 22 (2003): 151–185.
.gif)